The Costa Rican Social Security System (CCSS) will temporarily suspend the use of hydroxychloroquine and lopinavir-ritonavir as treatments for COVID-19 patients.
Costa Rican health authorities said Monday that the country will reevaluate its strategy of using hydroxychloroquine to treat coronavirus patients after the World Health Organization (WHO) suspended clinical trials of the drug.
Economic authorities in Costa Rica will meet with the International Monetary Fund (IMF) and ask for a line of financing that will allow it to face the financial blow caused by the coronavirus pandemic.
A Swiss pharmaceutical company has donated a substantial amount of hydroxychloroquine that will be used to treat patients hospitalized with COVID-19 in Costa Rica.
